NASDAQ:AXNX

Axonics Modulation Technologies News Headlines

$60.13
+0.13 (+0.22 %)
(As of 04/9/2021 12:00 AM ET)
Add
Compare
Today's Range
$58.08
Now: $60.13
$60.40
50-Day Range
$50.31
MA: $56.30
$60.00
52-Week Range
$26.29
Now: $60.13
$61.16
Volume368,964 shs
Average Volume573,461 shs
Market Capitalization$2.50 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.02

Headlines

Axonics Modulation Technologies (NASDAQ AXNX) News Headlines Today

SourceHeadline
Axonics Modulation Technologies (NASDAQ:AXNX) Price Target Raised to $71.00 at Needham & Company LLCAxonics Modulation Technologies (NASDAQ:AXNX) Price Target Raised to $71.00 at Needham & Company LLC
marketbeat.com - March 30 at 8:26 AM
Is Axonics Modulation Technologies (NASDAQ:AXNX) Using Too Much Debt?Is Axonics Modulation Technologies (NASDAQ:AXNX) Using Too Much Debt?
finance.yahoo.com - April 6 at 8:18 AM
Axonics Modulation Technologies (NASDAQ:AXNX) Given New $71.00 Price Target at Needham & Company LLCAxonics Modulation Technologies (NASDAQ:AXNX) Given New $71.00 Price Target at Needham & Company LLC
americanbankingnews.com - March 30 at 9:04 AM
Needham & Company LLC Raises Axonics Modulation Technologies (NASDAQ:AXNX) Price Target to $71.00Needham & Company LLC Raises Axonics Modulation Technologies (NASDAQ:AXNX) Price Target to $71.00
americanbankingnews.com - March 24 at 9:39 AM
Reviewing Axonics Modulation Technologies (NASDAQ:AXNX) & The Westaim (OTCMKTS:WEDXF)Reviewing Axonics Modulation Technologies (NASDAQ:AXNX) & The Westaim (OTCMKTS:WEDXF)
americanbankingnews.com - March 20 at 2:16 PM
Axonics® to Participate in the Barclays Global Healthcare ConferenceAxonics® to Participate in the Barclays Global Healthcare Conference
finance.yahoo.com - March 3 at 8:56 AM
Axonics® Announces Strategic Alliance for the Manufacture of New Non-Rechargeable Implantable Sacral Neuromodulation DeviceAxonics® Announces Strategic Alliance for the Manufacture of New Non-Rechargeable Implantable Sacral Neuromodulation Device
finance.yahoo.com - March 2 at 9:11 AM
Endotronix Appoints Industry Veteran Dan Dearen to Board of DirectorsEndotronix Appoints Industry Veteran Dan Dearen to Board of Directors
finance.yahoo.com - March 2 at 9:11 AM
Axonics® Expands into Stress Urinary Incontinence with the Acquisition of Bulkamid®Axonics® Expands into Stress Urinary Incontinence with the Acquisition of Bulkamid®
finance.yahoo.com - February 25 at 6:32 PM
Axonics® Reports Fourth Quarter and Fiscal Year 2020 ResultsAxonics® Reports Fourth Quarter and Fiscal Year 2020 Results
finance.yahoo.com - February 25 at 6:32 PM
Heres what Wall Street expects from Axonics Modulation Technologiess earnings reportHere's what Wall Street expects from Axonics Modulation Technologies's earnings report
markets.businessinsider.com - February 25 at 1:19 AM
Axonics Modulation Tech Earnings PreviewAxonics Modulation Tech Earnings Preview
finance.yahoo.com - February 24 at 3:19 PM
Axonics® to Report Fourth Quarter and Fiscal Year 2020 Financial Results on February 25, 2021Axonics® to Report Fourth Quarter and Fiscal Year 2020 Financial Results on February 25, 2021
finance.yahoo.com - February 22 at 7:59 PM
Axonics® to Participate in the Society for Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction 2021 Winter MeetingAxonics® to Participate in the Society for Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction 2021 Winter Meeting
finance.yahoo.com - February 18 at 9:50 AM
Axonics® Receives FDA Approval for Third-Generation Implantable NeurostimulatorAxonics® Receives FDA Approval for Third-Generation Implantable Neurostimulator
finance.yahoo.com - February 16 at 9:32 AM
Axonics® to Participate in the SVB Leerink Global Healthcare ConferenceAxonics® to Participate in the SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 11 at 8:06 AM
Axonics® Reports Preliminary Fourth Quarter and Fiscal Year 2020 RevenueAxonics® Reports Preliminary Fourth Quarter and Fiscal Year 2020 Revenue
finance.yahoo.com - January 25 at 5:27 PM
June 18th Options Now Available For Axonics Modulation Technologies (AXNX)June 18th Options Now Available For Axonics Modulation Technologies (AXNX)
nasdaq.com - January 22 at 2:46 PM
If You Had Bought Axonics Modulation Technologies (NASDAQ:AXNX) Shares A Year Ago Youd Have Earned 87% ReturnsIf You Had Bought Axonics Modulation Technologies (NASDAQ:AXNX) Shares A Year Ago You'd Have Earned 87% Returns
finance.yahoo.com - January 6 at 8:59 AM
Axonics® Announces Appointment of David M. Demski to Board of DirectorsAxonics® Announces Appointment of David M. Demski to Board of Directors
finance.yahoo.com - December 14 at 9:16 AM
Axonics® to Participate in Piper Sandler Virtual Healthcare ConferenceAxonics® to Participate in Piper Sandler Virtual Healthcare Conference
finance.yahoo.com - November 19 at 9:25 AM
Axonics® Announces Publication of Fecal Incontinence Study Results for Patients Treated with r-SNM® SystemAxonics® Announces Publication of Fecal Incontinence Study Results for Patients Treated with r-SNM® System
finance.yahoo.com - November 10 at 9:05 AM
US$61.00 - Thats What Analysts Think Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) Is Worth After These ResultsUS$61.00 - That's What Analysts Think Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) Is Worth After These Results
nasdaq.com - November 7 at 8:17 AM
Earnings Update: Heres Why Analysts Just Lifted Their Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) Price Target To US$61.00Earnings Update: Here's Why Analysts Just Lifted Their Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) Price Target To US$61.00
finance.yahoo.com - November 7 at 8:17 AM
Axonics Modulation Technologies, Inc.s (NASDAQ:AXNX) Intrinsic Value Is Potentially 54% Above Its Share PriceAxonics Modulation Technologies, Inc.'s (NASDAQ:AXNX) Intrinsic Value Is Potentially 54% Above Its Share Price
finance.yahoo.com - November 7 at 8:17 AM
Axonics Modulation Technologies Inc Registered Shs Stock , AXNXAxonics Modulation Technologies Inc Registered Shs Stock , AXNX
markets.businessinsider.com - November 5 at 12:43 PM
Axonics Modulation Technologies, Inc. (AXNX) CEO Raymond Cohen on Q3 2020 Results - Earnings Call TranscriptAxonics Modulation Technologies, Inc. (AXNX) CEO Raymond Cohen on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 5 at 1:05 AM
Axonics Modulation Technologies, Inc. (AXNX) CEO Raymond Cohen On Q3 2020 Results - Quick Earnings Call TranscriptAxonics Modulation Technologies, Inc. (AXNX) CEO Raymond Cohen On Q3 2020 Results - Quick Earnings Call Transcript
seekingalpha.com - November 4 at 8:05 PM
Axonics® Reports Third Quarter 2020 ResultsAxonics® Reports Third Quarter 2020 Results
finance.yahoo.com - November 4 at 8:05 PM
Axonics Modulation Technologies (AXNX) Reports Q3 Loss, Tops Revenue EstimatesAxonics Modulation Technologies (AXNX) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 4 at 8:05 PM
Axonics Modulation Technologies IncAxonics Modulation Technologies Inc
bloomberg.com - November 1 at 1:00 PM
Axonics® Submits PMA Supplement to FDA to Further Expand MRI LabelingAxonics® Submits PMA Supplement to FDA to Further Expand MRI Labeling
businesswire.com - October 29 at 6:30 AM
Axonics Modulation Technologies (AXNX) May Report Negative Earnings: Know the Trend Ahead of Next Weeks ReleaseAxonics Modulation Technologies (AXNX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - October 28 at 5:43 PM
Axonics® Launches ARTISTRY Study to Collect and Analyze Real-World Data of Patients Implanted with the Axonics r-SNM SystemAxonics® Launches ARTISTRY Study to Collect and Analyze Real-World Data of Patients Implanted with the Axonics r-SNM System
finance.yahoo.com - October 20 at 8:20 AM
Unusual Options Activity Insight: Axonics Modulation TechUnusual Options Activity Insight: Axonics Modulation Tech
benzinga.com - October 15 at 7:14 AM
Axonics Modulation Tech. Inc. R (0I3.SG)Axonics Modulation Tech. Inc. R (0I3.SG)
au.finance.yahoo.com - October 10 at 12:56 AM
Axonics (AXNX) Looks Good: Stock Adds 7.4% in SessionAxonics (AXNX) Looks Good: Stock Adds 7.4% in Session
nasdaq.com - September 30 at 12:28 PM
Medtronic scores win in patent dispute with AxonicsMedtronic scores win in patent dispute with Axonics
seekingalpha.com - September 27 at 8:39 AM
Axonics® Provides Update on Inter Partes Review ProceedingsAxonics® Provides Update on Inter Partes Review Proceedings
finance.yahoo.com - September 24 at 8:38 AM
Axonics® Reports 2-Year Clinical Results from ARTISAN-SNM Pivotal StudyAxonics® Reports 2-Year Clinical Results from ARTISAN-SNM Pivotal Study
finance.yahoo.com - September 10 at 9:57 AM
NICE Recommends Axonics® r-SNM System for Treating Overactive BladderNICE Recommends Axonics® r-SNM System for Treating Overactive Bladder
finance.yahoo.com - September 8 at 8:42 AM
Axonics to present detailed two-year data on urinary incontinence device September 9Axonics to present detailed two-year data on urinary incontinence device September 9
seekingalpha.com - September 4 at 8:15 PM
Axonics® to Participate in Upcoming Investor ConferencesAxonics® to Participate in Upcoming Investor Conferences
finance.yahoo.com - September 3 at 8:15 AM
Axonics® to Host Presentation of Full 2-Year Clinical Results from ARTISAN-SNM Pivotal Study on September 9Axonics® to Host Presentation of Full 2-Year Clinical Results from ARTISAN-SNM Pivotal Study on September 9
finance.yahoo.com - September 2 at 12:11 PM
Axonics Modulation Technologies (NASDAQ:AXNX) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, AnywayAxonics Modulation Technologies (NASDAQ:AXNX) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway
finance.yahoo.com - August 10 at 10:23 AM
Axonics Modulation Technologies (NASDAQ:AXNX) Is Using Debt SafelyAxonics Modulation Technologies (NASDAQ:AXNX) Is Using Debt Safely
finance.yahoo.com - August 10 at 10:23 AM
Axonics Modulation Technologies, Inc. (AXNX) CEO Raymond Cohen on Q2 2020 Results - Earnings Call TranscriptAxonics Modulation Technologies, Inc. (AXNX) CEO Raymond Cohen on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 6:10 PM
Axonics Modulation Technologies EPS beats by $0.06, beats on revenueAxonics Modulation Technologies EPS beats by $0.06, beats on revenue
seekingalpha.com - August 6 at 8:39 PM
Axonics® Reports Second Quarter 2020 ResultsAxonics® Reports Second Quarter 2020 Results
finance.yahoo.com - August 6 at 8:39 PM
Axonics Modulation Technologies (AXNX) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseAxonics Modulation Technologies (AXNX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - July 30 at 2:41 PM
Did Hedge Funds Make The Right Call On Axonics Modulation Technologies, Inc. (AXNX)Did Hedge Funds Make The Right Call On Axonics Modulation Technologies, Inc. (AXNX)
finance.yahoo.com - July 17 at 6:57 PM
This page was last updated on 4/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.